Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands
- PMID: 16033256
- DOI: 10.1021/jm048963m
Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands
Abstract
Structural modification of salvinorin A, the active component of Salvia divinorum, has resulted in the synthesis of novel neoclerodane diterpenes with opioid receptor affinity and activity. We report in this study a nonnitrogenous neoclerodane diterpene with mu opioid receptor affinity (13) that is an agonist at mu opioid receptors. This represents the identification of a novel structural class of mu opioid receptor agonists.
Similar articles
-
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.J Med Chem. 2007 Jul 26;50(15):3596-603. doi: 10.1021/jm070393d. Epub 2007 Jun 20. J Med Chem. 2007. PMID: 17580847
-
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.Bioorg Med Chem Lett. 2007 Nov 15;17(22):6111-5. doi: 10.1016/j.bmcl.2007.09.050. Epub 2007 Sep 15. Bioorg Med Chem Lett. 2007. PMID: 17904842 Free PMC article.
-
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.Bioorg Med Chem Lett. 2006 Jun 15;16(12):3170-4. doi: 10.1016/j.bmcl.2006.03.062. Epub 2006 Apr 18. Bioorg Med Chem Lett. 2006. PMID: 16621556
-
Neoclerodanes as atypical opioid receptor ligands.J Med Chem. 2013 May 9;56(9):3435-43. doi: 10.1021/jm400388u. Epub 2013 Apr 18. J Med Chem. 2013. PMID: 23548164 Free PMC article. Review.
-
Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.Life Sci. 2004 Oct 15;75(22):2615-9. doi: 10.1016/j.lfs.2004.07.008. Life Sci. 2004. PMID: 15369697 Review.
Cited by
-
Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor.ACS Med Chem Lett. 2017 Jul 5;8(7):694-700. doi: 10.1021/acsmedchemlett.7b00224. eCollection 2017 Jul 13. ACS Med Chem Lett. 2017. PMID: 28740600 Free PMC article.
-
Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.Pharmacol Rev. 2011 Dec;63(4):1001-19. doi: 10.1124/pr.111.004598. Epub 2011 Aug 26. Pharmacol Rev. 2011. PMID: 21873412 Free PMC article. Review.
-
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.Brain Res Bull. 2008 Sep 5;77(1):49-54. doi: 10.1016/j.brainresbull.2008.05.003. Epub 2008 Jun 4. Brain Res Bull. 2008. PMID: 18639745 Free PMC article.
-
Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor.Biochemistry. 2009 Jul 28;48(29):6898-908. doi: 10.1021/bi900605n. Biochemistry. 2009. PMID: 19555087 Free PMC article.
-
8-epi-Salvinorin B: crystal structure and affinity at the kappa opioid receptor.Beilstein J Org Chem. 2007 Jan 9;3:1. doi: 10.1186/1860-5397-3-1. Beilstein J Org Chem. 2007. PMID: 17212822 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials